Package 50242-260-01

{"route": ["SUBCUTANEOUS"], "spl_id": "c871709f-bb8a-4e51-91ad-31c75d43548e", "openfda": {"nui": ["N0000175661", "N0000020008", "N0000175531", "M0009499"], "unii": ["P188ANX8CK", "K16AIQ8CTM", "743QUY4VD8"], "rxcui": ["2382604", "2382609", "2383305", "2383307"], "spl_set_id": ["27dd5e6b-72cd-458d-a015-cf4dab5800da"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "pharm_class_epc": ["HER2/neu Receptor Antagonist [EPC]", "Endoglycosidase [EPC]"], "pharm_class_moa": ["HER2/Neu/cerbB2 Antagonists [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-01)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-260-01", "marketing_start_date": "20200629"}, {"sample": true, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-86)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-260-86", "marketing_start_date": "20210503"}], "brand_name": "Phesgo", "product_id": "50242-260_c871709f-bb8a-4e51-91ad-31c75d43548e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Endoglycosidase [EPC]", "Glycoside Hydrolases [CS]", "HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/neu Receptor Antagonist [EPC]", "HER2/neu Receptor Antagonist [EPC]"], "product_ndc": "50242-260", "generic_name": "pertuzumab, trastuzumab, and hyaluronidase-zzxf", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phesgo", "active_ingredients": [{"name": "HYALURONIDASE (HUMAN RECOMBINANT)", "strength": "20000 U/10mL"}, {"name": "PERTUZUMAB", "strength": "600 mg/10mL"}, {"name": "TRASTUZUMAB", "strength": "600 mg/10mL"}], "application_number": "BLA761170", "marketing_category": "BLA", "marketing_start_date": "20200629", "listing_expiration_date": "20261231"}